radiopharmaceuticals

Preferred Label : radiopharmaceuticals;

Obsolete resource : false;

MeSH definition : Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161);

MeSH synonym : Radiopharmaceutical;

MeSH annotation : pharmaceuticals as source of radiation in radiother & radioisotope scanning; D25-26 qualif;

Wikipedia link : https://en.wikipedia.org/wiki/Radiopharmaceuticals;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D019275;

UMLS CUI

C0182638;

ATC code(s)
- fluoroethylcholine (18F) [ATC Code]
- sodium iodide (131i) [ATC Code]
ATC code(s)
- diagnostic radiopharmaceuticals [ATC Code]
- flutemetamol (18F) [ATC Code]
- gallium (68Ga) gozetotide [ATC Code]
- iodine (131I) omburtamab [ATC Code]
- other antiinflammatory therapeutic radiopharmaceuticals [ATC Code]
- other cardiovascular system diagnostic radiopharmaceuticals [ATC Code]
- other central nervous system diagnostic radiopharmaceuticals [ATC Code]
- other diagnostic radiopharmaceuticals [ATC Code]
- other diagnostic radiopharmaceuticals for inflammation and infection detection [ATC Code]
- other diagnostic radiopharmaceuticals for tumour detection [ATC Code]
- other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals [ATC Code]
- other renal system diagnostic radiopharmaceuticals [ATC Code]
- other respiratory system diagnostic radiopharmaceuticals [ATC Code]
- other therapeutic radiopharmaceuticals [ATC Code]
- sodium fluoride (18F) [ATC Code]
- technetium (99mTc) etarfolatide [ATC Code]
- technetium (99mTc) hynic-octreotide [ATC Code]
- therapeutic radiopharmaceuticals [ATC Code]
- various diagnostic radiopharmaceuticals [ATC Code]
- various pain palliation radiopharmaceuticals [ATC Code]
- various therapeutic radiopharmaceuticals [ATC Code]
- various thyroid diagnostic radiopharmaceuticals [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Radiopharmaceutical poisoning (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Radiopharmaceutical Compound [NCIt concept]
- Radiopharmaceuticals (product) [SNOMED CT concept]
- radiopharmaceutical [Radlex concept]
Indexing information
- ((177)Lu)Lu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methane-phosphonic acid) [MeSH Supplementary Concept]
- (123I)INER [MeSH Supplementary Concept]
- (166)Ho-oxine-lipiodol [MeSH Supplementary Concept]
- (177)Lu-oxine-lipiodol [MeSH Supplementary Concept]
- (18)F-GE067 [MeSH Supplementary Concept]
- (188)Rhenium tin-colloid [MeSH Supplementary Concept]
- (18F)1-(2'-deoxy-2'-arabinofuranosyl)cytosine [MeSH Supplementary Concept]
- (4S)-4-(3-(18F)fluoropropyl)-L-glutamate [MeSH Supplementary Concept]
- (64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2) [MeSH Supplementary Concept]
- (99m)Tc 5-Amino-1,3-bis(ethylamine-(N,N dimethyl diphosphonic acid) acetamido) benzene [MeSH Supplementary Concept]
- (R)-(11C)1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide [MeSH Supplementary Concept]
- (Z)-2-((1H-indazol-3-yl)methylene)-6-((11)C)methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one [MeSH Supplementary Concept]
- 1-(18F)fluoro-3,6-dioxatetracosane [MeSH Supplementary Concept]
- 11-methoxy-4,16-difluoroestradiol [MeSH Supplementary Concept]
- 188Re-DTPA-deoxyglucose [MeSH Supplementary Concept]
- 18F-fluorobenzoyl-lisinopril [MeSH Supplementary Concept]
- 2-(4-aminophenyl)-6-(2-fluoroethoxy)quinoline [MeSH Supplementary Concept]
- 2beta-carbo-2'-(18F)fluoroethoxy-3beta-(4-bromo-phenyl)tropane [MeSH Supplementary Concept]
- 3-(4,5-dihydrooxazol-2-yl)phenyl (5-fluoropentyl)carbamate [MeSH Supplementary Concept]
- 4-((3-iodophenyl)amino)-7-(2-(2-(2-(2-(2-(2-(18F)fluoroethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)quinazoline-6-yl-acrylamide [MeSH Supplementary Concept]
- 4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide [MeSH Supplementary Concept]
- 5-(3-fluoropropyloxy)tryptophan [MeSH Supplementary Concept]
- 5-methyl-8-(4-methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid (4-morpholin-4-yl-phenyl)amide [MeSH Supplementary Concept]
- 6,7-dimethoxy-2-(6-methoxynaphthalen-2-ylmethyl)-1,2,3,4-tetrahydroisoquinoline [MeSH Supplementary Concept]
- 64Cu-DOTA-conatumumab [MeSH Supplementary Concept]
- 68Ga-DOTA-octreotide [MeSH Supplementary Concept]
- 89Zr-rituximab [MeSH Supplementary Concept]
- 9-fluoro-3,4-methyleneheptadecanoic acid [MeSH Supplementary Concept]
- 99mTc-TOR-G [MeSH Supplementary Concept]
- DO3A-CH2CO-G-4-aminobenzoyl-Q-W-A-V-G-H-L-M-NH2 [MeSH Supplementary Concept]
- HX4 compound [MeSH Supplementary Concept]
- JNJ41510417 [MeSH Supplementary Concept]
- MK-8278 [MeSH Supplementary Concept]
- N-((2-pyrolidinyl)methyl)-2,3-dimethoxy-5-(3'-fluoropropyl)benzamide [MeSH Supplementary Concept]
- N-(2-(diethylamino)ethyl)-2-iodobenzamide [MeSH Supplementary Concept]
- N-(2-fluoropropionyl)methionine [MeSH Supplementary Concept]
- PSS223 [MeSH Supplementary Concept]
- besilesomab [MeSH Supplementary Concept]
- cFLFLFK-PEG-64Cu [MeSH Supplementary Concept]
- flubrobenguane [MeSH Supplementary Concept]
- fluoromethyldeoxyspergualin [MeSH Supplementary Concept]
- pyrithione [MeSH Supplementary Concept]
- re-diethylenetriamine pentaacetic acid-glucosamine [MeSH Supplementary Concept]
- technetium 99m HYNIC-RGD [MeSH Supplementary Concept]
- technetium tc 99m CIBCNSH3 [MeSH Supplementary Concept]
- technetium tc 99m N-(2-hydroxyethyl) ethlenediamine-1,1,2-tri(methylene phosphonic acid) [MeSH Supplementary Concept]
- technetium tc 99m interleukin 2 [MeSH Supplementary Concept]
Record concept(s)
- radiopharmaceuticals [MeSH concept]
See also (suggested by CISMeF)
- radiography [MeSH Descriptor]
- radiotherapy [MeSH Descriptor]
Semantic type(s)
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (11)C-Me-NB1 [MeSH Supplementary Concept]
- (177)Lu-DOTA-EB-TATE [MeSH Supplementary Concept]
- (177)Lu-lilotomab satetraxetan [MeSH Supplementary Concept]
- (18 F)D3FSP [MeSH Supplementary Concept]
- (18)F-JNJ-64413739 [MeSH Supplementary Concept]
- (225)Ac-PSMA-617 [MeSH Supplementary Concept]
- (44Sc)Sc-PSMA-617 [MeSH Supplementary Concept]
- (89)Zr-girentuximab [MeSH Supplementary Concept]
- (89Zr)oxinate(4) [MeSH Supplementary Concept]
- 11C-PS13 [MeSH Supplementary Concept]
- 177Lu-DKFZ-PSMA-617 [MeSH Supplementary Concept]
- 177Lu-EB-PSMA-617 [MeSH Supplementary Concept]
- 177Lu-PSMA-617 [MeSH Supplementary Concept]
- 18F-FC119S [MeSH Supplementary Concept]
- 18F-JK-PSMA-7 [MeSH Supplementary Concept]
- 2-deoxy-2-fluorogalactose [MeSH Supplementary Concept]
- 2beta-carbomethoxy-3beta-(4-iodophenyl)tropane [MeSH Supplementary Concept]
- 3-Iodobenzylguanidine [MeSH Descriptor]
- 3-N-(2-fluoroethyl)spiperone [MeSH Supplementary Concept]
- 3-iodo-alpha-methyltyrosine [MeSH Supplementary Concept]
- 68Ga-NOTA-RM26 [MeSH Supplementary Concept]
- 89Zr-MSB0010853 [MeSH Supplementary Concept]
- 89Zr-bevacizumab [MeSH Supplementary Concept]
- 89Zr-rituximab [MeSH Supplementary Concept]
- AS2471907 [MeSH Supplementary Concept]
- Al18F-NOTA-octreotide [MeSH Supplementary Concept]
- BAY 2287411 [MeSH Supplementary Concept]
- BMS 181321 [MeSH Supplementary Concept]
- EKAP compound [MeSH Supplementary Concept]
- FAPI-46 [MeSH Supplementary Concept]
- FEKAP [MeSH Supplementary Concept]
- HYNIC-3PRGD(2) [MeSH Supplementary Concept]
- JNJ-64326067 [MeSH Supplementary Concept]
- LSN3172176 [MeSH Supplementary Concept]
- PSMA-BCH [MeSH Supplementary Concept]
- SDZ 215-811 [MeSH Supplementary Concept]
- acetylacetonate-poly(L-lactic Acid) [MeSH Supplementary Concept]
- carbon-11 methionine [MeSH Supplementary Concept]
- edotreotide [MeSH Supplementary Concept]
- edotreotide lutetium LU-177 [MeSH Supplementary Concept]
- fluoroazomycin arabinoside [MeSH Supplementary Concept]
- fluorodeoxyglucose F18 [MeSH Descriptor]
- flutemetamol [MeSH Supplementary Concept]
- gallium 68 PSMA-11 [MeSH Supplementary Concept]
- gallium citrate [MeSH Supplementary Concept]
- gold colloid, radioactive [MeSH Descriptor]
- indium-111-octreotide [MeSH Supplementary Concept]
- iofetamine [MeSH Descriptor]
- lutetium Lu 177 dotatate [MeSH Supplementary Concept]
- serum albumin, Radio-Iodinated [MeSH Descriptor]
- sodium pertechnetate tc 99m [MeSH Descriptor]
- technetium 99m tricarbonyl bevacizumab [MeSH Supplementary Concept]
- technetium Tc 99m Q12 [MeSH Supplementary Concept]
- technetium Tc 99m bicisate [MeSH Supplementary Concept]
- technetium Tc 99m gluceptate [MeSH Supplementary Concept]
- technetium Tc 99m gluconate [MeSH Supplementary Concept]
- technetium Tc 99m hydroxymethylene diphosphonate [MeSH Supplementary Concept]
- technetium Tc 99m mebrofenin [MeSH Supplementary Concept]
- technetium Tc 99m teboroxime [MeSH Supplementary Concept]
- technetium Tc 99m tin colloid [MeSH Supplementary Concept]
- technetium phytate [MeSH Supplementary Concept]
- technetium tc 99m (para-butyl)iminodiacetic acid [MeSH Supplementary Concept]
- technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid [MeSH Supplementary Concept]
- technetium tc 99m DTPA-galactosyl-human serum albumin [MeSH Supplementary Concept]
- technetium tc 99m PIPIDA [MeSH Supplementary Concept]
- technetium tc 99m TRODAT-1 [MeSH Supplementary Concept]
- technetium tc 99m aggregated albumin [MeSH Descriptor]
- technetium tc 99m bis(1,2-dimethylphosphino)ethane [MeSH Supplementary Concept]
- technetium tc 99m dextran [MeSH Supplementary Concept]
- technetium tc 99m diethyl-iminodiacetic acid [MeSH Descriptor]
- technetium tc 99m dimercaptosuccinic acid [MeSH Descriptor]
- technetium tc 99m diphosphonate [MeSH Supplementary Concept]
- technetium tc 99m disofenin [MeSH Descriptor]
- technetium tc 99m etidronate [MeSH Supplementary Concept]
- technetium tc 99m exametazime [MeSH Descriptor]
- technetium tc 99m iminodiacetic acid [MeSH Supplementary Concept]
- technetium tc 99m lidofenin [MeSH Descriptor]
- technetium tc 99m medronate [MeSH Descriptor]
- technetium tc 99m mertiatide [MeSH Descriptor]
- technetium tc 99m neogalactoalbumin [MeSH Supplementary Concept]
- technetium tc 99m pentetate [MeSH Descriptor]
- technetium tc 99m plasmin [MeSH Supplementary Concept]
- technetium tc 99m pyridoxyl-5-methyltryptophan [MeSH Supplementary Concept]
- technetium tc 99m pyrophosphate [MeSH Descriptor]
- technetium tc 99m rhenium colloid [MeSH Supplementary Concept]
- technetium tc 99m sestamibi [MeSH Descriptor]
- technetium tc 99m sucralfate [MeSH Supplementary Concept]
- technetium tc 99m sulfur colloid [MeSH Descriptor]
- technetium tc 99m-ethylenedicysteine [MeSH Supplementary Concept]
- technetium tc-99m tetrofosmin [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Radiopharmaceutical Compound [NCIt concept]
- Radiopharmaceuticals (product) [SNOMED CT concept]
- radiopharmaceutical [Radlex concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients